EFTEKHARI ET AL.
7
128.5, 127.9, 122.7, 120.2, 120.3, 115.1, 114.9, 111.2, 55.8,
and 47.8.
5 | CONCLUSIONS
Finally, we were able to carry out an efficient reaction, one-
pot, low-time, and high efficiency, without the use of heat
and reflux for the production of derivatives of 1,3-diaryl-
2-n-azaphenalene and n-acyl-1,3-diaryl-2-n-azaphenylene
from a mixture of five compounds of 2, 7-naphthalene diol,
aldehydes, ammonia derivatives (ammonium acetate or
ammonium hydrogen phosphate), and solvent (water
and alcohol) in the presence of Fe3O4@L-arginine
nanocatalysts.
As shown in Table 1, on the nanoscale, the reaction time
is, on average, one-fifth of the time when the catalyst is not
used, while the efficiency of the reactions is improved by
20–50%. It also saves energy due to nonuse of heat, and the
synthesis of compounds makes economical.
4.2 | B1:N-acetyl-4,9-dihydroxy-1,3-di(phenyl)-
2,3-dihydro-2-azaphenalene
IR (KBr): νmax = 3,300–3,000, 2,818, 2,708, 1,626, 1,585,
1,516, 1,431, 1,396, 1,327, 1,273, 1,130, 1,028, 881, 736,
699, and 671 cm−1; 1H NMR (500 MHz, DMSO-d6):
δ = 9.01 (br, 2H, disappeared on D2O exchange), 7.56 (d,
J = 7.7 Hz, 2H), 7.21(t, J = 7.6, 4H), 7.16(t, J = 7.6, 2H),
7.08 (d, J = 7.0 Hz, 4H), 6.86 (d, J = 8.7 Hz, 2H), 5.19 (s,
2H), and 1.91 (s, 3H); 13C NMR(125 MHz, DMSO-d6):
δ = 172.5, 150.5, 145.2, 132.2, 128.3, 128.1, 127.7, 126.6,
122.7, 116.2, 115.2, and 53.9.
In addition, Fe3O4 was considered as a nanocatalyst
because of the availability, low toxicity, recyclability, and
easy separation of the reaction solution. The catalyst can be
used five times without losing its function.
4.3 | B4:N-acetyl-4,9-dihydroxy-1,3-di
(4-hydroxyphenyl) -2,3-dihydro-2-azaphenalenes
The Fe3O4@L-arginine nanocatalyst was characterized
using FT-IR spectroscopy, XRD, and FESEM.
IR (KBr): νmax = 3,630, 3,319, 3,211, 3,015, 2,823, 2,696,
1,623,1,604, 1,543, 1,511, 1,429, 1,309, 1,246, 1,174, 1,130,
836, 773, and 657 cm−1; 1H NMR (500 MHz, DMSO-d6):
δ = 8.92 (br, 4H , disappeared on D2O exchange), 7.58 (d,
J = 7.4 Hz, 2H), 7.01–6.88 (m, 6H), 6.63–6.50 (m, 4H), 5.18
(s, 2H), and 1.90 (s, 3H); 13C NMR(125 MHz, DMSO-d6):
δ = 172.74, 156.72, 150.9, 132.2, 131.75, 129.59, 128.12,
122.5, 115.3, 115.1, 114.8, 53.3, and 21.6.
ACKNOWLEDGMENTS
We gratefully acknowledge the Department of Organic
Chemistry, Faculty of Pharmaceutical Chemistry, Tehran
Medical Sciences, Islamic Azad University, Tehran, Iran.
ORCID
4.4 | B9:N-acetyl-4,9-dihydroxy-1,3-di
(2-methylphenyl)-2,3-dihydro-2-azaphenalene
IR (KBr): νmax = 3,271–2,968, 1,624, 1,511, 1,411, 1,316,
1,039, 840, 758, and 699 cm−1. 1H NMR (500 MHz,
DMSO-d6): δ = 9.11 (br, 2H, disappeared on D2O
exchange), 7.55 (d, J = 8.5, 2H), 7.09 (t, J = 7.6, 2H), 6.96
(d, J = 8.7, 2H), 6.91 (m, 2H), 6.84 (m, 4H), 5.15 (s, 2H),
2.20 (s, 6H), and 1.91 (S, 3H). 13C NMR (125 MHz,
DMSO-d6): δ = 172.4, 150.5, 144.9, 136.99, 132.1, 128.9,
128.6, 127.6, 127.32, 125.45, 122.7, 116.3, 115.2, 53.89,
21.6, and 21.5.
REFERENCES
[1] N. 1-Foroughifar, A. Mobinikhaledi, H. Moghanian, Synth. Commun.
2010, 40, 1812.
[2] L. F. Tietze, Chem. Rev. 1996, 96, 115.
[3] A. Domling, I. Ugi, Angew. Chem. Int. Ed. 2000, 39, 3169.
[4] For a special issue on MCRs, see Tetrahedron 2005, 61, 11299.
[5] L. Weber, Drug Disc. Today 2002, 7, 143.
[6] A. Dömling, Curr. Opin. Chem. Biol. 2002, 6, 306.
[7] N. Foroughifar, A. Mobinikhaledi, H. Moghanian, Chem. Lett. 2010, 39
(3), 180.
[8] I. Szatmári, F. Fülöp, Curr. Org. Synth. 2004, 1, 155.
[9] A. Mobinikhaledi, N. Foroughifar, H. Moghanian, R. Mozaffari, Res.
Chem. Intermed. 2015, 41, 6523.
4.5 | B10:N-acetyl-4,9-dihydroxy-1,3-di
[10] R. C. Haddon, Nature 1975, 256, 394.
[11] M. E. Itkis, X. Chi, A. W. Cordes, R. C. Haddon, Science 2002, 296, 1443.
[12] S. Shimizu, H. Zhu, N. Kobayashi, Chemistry 2010, 16, 11151.
[13] J. L. Hodgson, M. Namazian, S. E. Bottle, M. L. Coote, J. Phys. Chem. A
2007, 111, 13595.
[14] D. Daloze, J.-C. Braekman, J. Pasteels, Chemoecology 1994, 5, 173.
[15] M. Gholami Dehbalaei, N. Foroughifar, A. Khajeh-Amiri, H. Pasdar,
J. Chin. Chem. Soc. 2018, 65, 1356.
[16] M. G. Dehbalaei, N. Foroughifar, H. Pasdar, A. Khajeh-Amiri, New
J. Chem. 2018, 42(1), 327.
[17] J. T. Hu, T. W. Odom, C. M. Lieber, Acc. Chem. Res. 1999, 32, 435.
[18] T. Tamoradi, A. Ghorbani-Choghamarani, M. Ghadermazi, New J. Chem.
2017, 41, 11714.
(2-chlorophenyl)-2,3-dihydro-2-azaphenalenes
IR (KBr): νmax = 3,455–2,835, 3,315, 1,618, 1,442, 1,373,
1,225, 1,041, 938, 835, and 748 cm−1; 1H NMR
(125 MHz,DMSOd6): δ = 9.55 (S, 2H), 7.74 (d, J = 7.6 Hz,
2H), 7.07 (d, J = 7.6 Hz, 2H), 7.00 (d, J = 5.7 Hz, 2H), 6.80
(m, 2H), 6.58 (m, 2H), 6.15 (d, J = 7.4 Hz, 2H), 5.71 (s, 2H),
and 1.92 (s, 2H); 13CNMR(125 MHz, DMSO-d6): δ =
172.49, 151.35, 133.3, 130.57, 129.15, 128.63, 128.06,
126.09, 122.65, 114.94, 104.97, 51.4, and 21.63.
[19] A. S. K. Hashmi, G. J. Hutchings, Angew. Chem., Int. Ed. 2006, 45, 7896.